[HTML][HTML] MiR-338* targeting smoothened to inhibit pulmonary fibrosis by epithelial-mesenchymal transition
Y Zhuang, J Dai, Y Wang, H Zhang, X Li… - American journal of …, 2016 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease involving pulmonary injury
associated with tissue repair, dysfunction and fibrosis. Recent studies indicate that some …
associated with tissue repair, dysfunction and fibrosis. Recent studies indicate that some …
[HTML][HTML] MiR-338* suppresses fibrotic pathogenesis in pulmonary fibrosis through targeting LPA1
Y Zhuang, J Dai, Y Wang, H Zhang, X Li… - American journal of …, 2016 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease involving pulmonary injury
associated with tissue repair, dysfunction and fibrosis. MicroRNAs (miRNAs), as gene …
associated with tissue repair, dysfunction and fibrosis. MicroRNAs (miRNAs), as gene …
miR‑320a‑3P alleviates the epithelial‑mesenchymal transition of A549 cells by activation of STAT3/SMAD3 signaling in a pulmonary fibrosis model
X Wang, J Wang, G Huang, Y Li… - Molecular Medicine …, 2021 - spandidos-publications.com
Pulmonary fibrosis (PF) is a common, chronic and incurable lung disease, in which the lungs
become scarred over time. MicroRNAs (miRNAs/miRs) serve key roles in various biological …
become scarred over time. MicroRNAs (miRNAs/miRs) serve key roles in various biological …
The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis
C Liang, X Li, L Zhang, D Cui, X Quan… - … and Molecular Pathology, 2015 - Elsevier
Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic lung disease with an
undefined etiology and no effective treatments. By binding to cell surface receptors …
undefined etiology and no effective treatments. By binding to cell surface receptors …
miR-130b-3p modulates epithelial-mesenchymal crosstalk in lung fibrosis by targeting IGF-1
S Li, J Geng, X Xu, X Huang, D Leng, D Jiang, J Liang… - PloS one, 2016 - journals.plos.org
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and usually lethal fibrotic lung
disease with largely unknown etiology and pathogenesis. Evidence suggests microRNAs …
disease with largely unknown etiology and pathogenesis. Evidence suggests microRNAs …
Integrated analyses identify the involvement of microRNA-26a in epithelial–mesenchymal transition during idiopathic pulmonary fibrosis
H Liang, Y Gu, T Li, Y Zhang, L Huangfu, M Hu… - Cell death & …, 2014 - nature.com
Abstract Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and highly lethal
fibrotic lung disease with poor treatment and unknown etiology. Emerging evidence …
fibrotic lung disease with poor treatment and unknown etiology. Emerging evidence …
The anti-fibrotic effects and mechanisms of microRNA-486-5p in pulmonary fibrosis
X Ji, B Wu, J Fan, R Han, C Luo, T Wang, J Yang… - Scientific reports, 2015 - nature.com
To identify microRNAs (miRNAs, miRs) with potential roles in lung fibrogenesis, we
performed genome-wide profiling of miRNA expression in lung tissues from a silica-induced …
performed genome-wide profiling of miRNA expression in lung tissues from a silica-induced …
MicroRNA-326 regulates profibrotic functions of transforming growth factor-β in pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a fatal disorder resulting from the progressive
remodeling of lungs, with no known effective treatment. Although transforming growth factor …
remodeling of lungs, with no known effective treatment. Although transforming growth factor …
The role of miR-497-5p in myofibroblast differentiation of LR-MSCs and pulmonary fibrogenesis
X Chen, C Shi, C Wang, W Liu, Y Chu, Z Xiang, K Hu… - Scientific reports, 2017 - nature.com
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal fibrotic lung disease
characterized by profound changes in stem cell differentiation, epithelial cell phenotypes …
characterized by profound changes in stem cell differentiation, epithelial cell phenotypes …
MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation
Aberrant proliferation and activation of lung fibroblasts contribute to the initiation and
progression of idiopathic pulmonary fibrosis (IPF). However, the mechanisms responsible for …
progression of idiopathic pulmonary fibrosis (IPF). However, the mechanisms responsible for …